Page last updated: 2024-08-24

meglumine antimoniate and Recrudescence

meglumine antimoniate has been researched along with Recrudescence in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.44)	18.7374
1990's	15 (33.33)	18.2507
2000's	15 (33.33)	29.6817
2010's	10 (22.22)	24.3611
2020's	3 (6.67)	2.80

Authors

Authors	Studies
Broere, F; de Jong, MK; Piek, CJ; Rappoldt, A	1
Camara, L; Queirós, J; Ribeiro, R; Teófilo, E	1
Bartoloni, A; Basile, G; Bresci, S; Cristofaro, G; Di Muccio, T; Gaiera, G; Gallo, O; Gradoni, L; Gramiccia, M; Locatello, LG; Maggiore, G; Novelli, A; Piccica, M; Vellere, I; Zammarchi, L	1
Aflatoonian, MR; Amiri, R; Bamorovat, M; Borhani Zarandi, M; Dabiri, S; Hassanzadeh, S; Heshmatkhah, A; Karamoozian, A; Kheirandish, R; Shamsi Meymandi, S; Sharifi, F; Sharifi, I	1
Antônio, LF; Brahim, LR; Costa, ADD; Dias, CMG; Duque, MCO; Lyra, MR; Marzochi, MCA; Paes, LEC; Pimentel, MIF; Schubach, AO; Valete-Rosalino, CM; Vieira, IF	1
Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN	1
Bedoya, A; Cruz-Barrera, ML; Daza, CD; Echeverry, MC; Lopez, MC; Mariño, ML; Perez-Franco, JE; Robayo, ML; Saavedra, CH	1
Akhdari, N; Amal, S; Hocar, O; Ouadi, Z; Tassi, N	1
Barbosa, JF; Caligiorne, RB; de Figueiredo, SM; Lyon, S	1
Caljon, G; Croft, SL; Guerin, PJ; Hendrickx, S; Maes, L	1
García-Lázaro, M; Natera, C; Rivero, A; Villar, C	1
Arik Yilmaz, E; Tanir, G; Taylan Ozkan, A; Tuygun, N	1
Nilforoushzadeh, MA; Sadeghian, G; Shirani-Bidabadi, L; Ziaei, H	1
Butsashvili, M; Chubabria, G; Kajaia, M; Kamkamidze, G; Kokaia, N; McNutt, LA; Morse, DL; Zenaishvili, O	1
López, L; Robayo, M; Vargas, M; Vélez, ID	1
Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P	1
Colomba, C; Frasca Polara, V; Salsa, L; Scarlata, F; Titone, L	1
Amari, L; Belhaj, S; Ben Chaabene, T; Goubontini, A; Kilani, B	1
Bonello, FL; de Lima, VM; Feitosa, MM; Ikeda-Garcia, FA; Lopes, RS; Marques, FJ; Morinishi, CK; Perri, SH; Zanette, MF	1
Carvalho, SF; Costa, RT; De Almeida Silva, L; Nascimento, E; Prata, A; Rodrigues, V; Romero, HD	1
Cortes, S; João, A; Pereira, MA; Santos-Gomes, GM	1
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL	1
Dabiri, SH; Esfandiarpour, I	1
Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A	1
Fisher, BK; Schewach-Millet, M; Semah, D	1
Ahmad, E; Ghahramani, N; Javid, R; Malek Hosseini, SA; Nezakatgoo, N; Salahi, H	1
Aminjavaheri, M; Momeni, AZ	1
Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E	1
Ali, A; Berhe, N; Hailu, A; Yeneneh, H	1
Aragort de Rossell, R; de Jesús de Durán, R; Rodríguez, AM; Rossell, O	1
Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E	1
Dumon, H; Gambarelli, F; Garnier, JM; Kaplanski, S; Piarroux, R; Unal, D	1
Caramello, P; Millesimo, M; Savoia, D; Zucca, M	1
Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J	1
Slappendel, RJ; Teske, E	1
Camma, C; Cascio, A; Giordano, S; Gradoni, L; Gramiccia, M; Russo, R; Scalone, A; Scarlata, F; Titone, L	1
Goncalves-Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A	1
Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A	1
Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A	1
Barreto, SM; Krettli, AU; Lima e Costa, MF; Passos, VM; Romanha, AJ; Volpini, AC	1
Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B	1
Banzet, S	1
Antinori, S; Cascio, A; Colomba, C; Orobello, M; Paterson, D; Titone, L	1
Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S	1
Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA	1

Reviews

2 review(s) available for meglumine antimoniate and Recrudescence

Article	Year
Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology, 2018, Volume: 145, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Parasitic Sensitivity Tests; Phosphorylcholine; Psychodidae; Recurrence	2018
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome	2004

Article

Year

Evaluating drug resistance in visceral leishmaniasis: the challenges.

Parasitology, 2018, Volume: 145, Issue:4

Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Parasitic Sensitivity Tests; Phosphorylcholine; Psychodidae; Recurrence

2018

[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].

Pathologie-biologie, 2004, Volume: 52, Issue:2

Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome

2004

Trials

5 trial(s) available for meglumine antimoniate and Recrudescence

Article	Year
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials, 2012, May-17, Volume: 13 Topics: Adult; Aged; Antiprotozoal Agents; Chi-Square Distribution; Colombia; Drug Administration Schedule; Female; Health Facilities; Humans; Hyperthermia, Induced; Injections, Intramuscular; Kaplan-Meier Estimate; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Facilities; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome	2012
Treatment of recurrent cutaneous Leishmaniasis. International journal of dermatology, 1995, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	1995
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. The American journal of medicine, 1996, Volume: 100, Issue:5 Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors	1996
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial. The veterinary quarterly, 1997, Volume: 19, Issue:1 Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome	1997
A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years). The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:6 Topics: Adolescent; Adult; Age Factors; Animals; Antiprotozoal Agents; Brazil; Child; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mucous Membrane; Organometallic Compounds; Recurrence; Treatment Failure	1997

Other Studies

38 other study(ies) available for meglumine antimoniate and Recrudescence

Article	Year
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy. Parasites & vectors, 2023, May-15, Volume: 16, Issue:1 Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Meglumine Antimoniate; Prognosis; Recurrence; Urea	2023
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients. BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12 Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome	2019
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Administration, Intravenous; Aged; Amphotericin B; Antiprotozoal Agents; Argentina; Azoles; Drug Therapy, Combination; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentamidine; Recurrence	2020
Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:1 Topics: Adolescent; Case-Control Studies; Child; Chronic Disease; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Polymerase Chain Reaction; Prospective Studies; Recurrence; Risk Factors; Treatment Failure; Treatment Outcome	2021
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). Memorias do Instituto Oswaldo Cruz, 2017, Volume: 112, Issue:12 Topics: Adult; Antiprotozoal Agents; Cohort Studies; Female; Humans; Incidence; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome	2017
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult	2015
Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:5 Topics: Adult; Antiprotozoal Agents; Cohort Studies; Cross-Sectional Studies; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Failure; U937 Cells; Young Adult	2016
[Polymorphic lesions of cutaneous leishmaniasis revealing human immunodeficiency virus infection]. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:7 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Endemic Diseases; Female; Fluconazole; Herpes Zoster; Humans; Immunocompromised Host; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Recurrence; Viremia; Young Adult	2016
An 8-Year Retrospective Study of Human Visceral Leishmaniasis. Current clinical pharmacology, 2016, Volume: 11, Issue:4 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Sex Distribution; Young Adult	2016
[Raised tattoos in a human-immunodeficiency-virus-infected patient]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:10 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine	2009
Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience. Turkiye parazitolojii dergisi, 2009, Volume: 33, Issue:4 Topics: Adolescent; Age Distribution; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome; Turkey	2009
Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2010, Volume: 16, Issue:3 Topics: Adolescent; Adult; Antiprotozoal Agents; Chronic Disease; Cicatrix; Diagnosis, Differential; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Lupus Vulgaris; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Outcome	2010
Risk factors for relapse of visceral leishmaniasis in Georgia. Tropical medicine & international health : TM & IH, 2011, Volume: 16, Issue:2 Topics: Age Factors; Antiprotozoal Agents; Child; Child, Preschool; Delayed Diagnosis; Female; Georgia (Republic); Hemoglobins; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Recurrence; Risk Factors	2011
[Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy]. Le infezioni in medicina, 2004, Volume: 12, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Female; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Recurrence	2004
[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B]. La Tunisie medicale, 2004, Volume: 82, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Follow-Up Studies; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors	2004
Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Veterinary parasitology, 2007, Feb-28, Volume: 143, Issue:3-4 Topics: Animals; Antiprotozoal Agents; Carrier State; Disease Reservoirs; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome	2007
Immunologic tests in patients after clinical cure of visceral leishmaniasis. The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:4 Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Chromatography; Dogs; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunologic Tests; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Skin Tests; Time Factors	2006
Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine, 2006, Volume: 53, Issue:10 Topics: Allopurinol; Animals; Antiprotozoal Agents; Bone Marrow; Disease Transmission, Infectious; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Skin; Treatment Outcome; Trifluralin	2006
An HIV-positive man with tattoo induration. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing	2007
Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. International journal of dermatology, 2007, Volume: 46, Issue:8 Topics: Adolescent; Adult; Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Face; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	2007
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002]. Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:4 Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia	2007
Leishmaniasis recidivans treated with sodium stibogluconate. Cutis, 1981, Volume: 28, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence	1981
A case report of Kala-Azar in a kidney transplant patient. Transplantation proceedings, 1995, Volume: 27, Issue:5 Topics: Adult; Allopurinol; Antiprotozoal Agents; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Splenectomy; Splenomegaly; Time Factors	1995
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection]. Medicina clinica, 1995, Apr-22, Volume: 104, Issue:15 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence	1995
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation. Acta tropica, 1994, Volume: 57, Issue:1 Topics: Adolescent; Adult; Age Factors; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sex Factors; Treatment Outcome	1994
Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions? Annals of tropical medicine and parasitology, 1993, Volume: 87, Issue:1 Topics: Animals; Antiprotozoal Agents; Disease Susceptibility; Female; Hyperthermia, Induced; Immunologic Memory; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Recurrence	1993
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:4 Topics: Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunity, Cellular; Infant; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Recurrence	1996
Evaluation of the immune response in visceral leishmaniasis. Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1 Topics: Agglutination Tests; Animals; Antiprotozoal Agents; Clinical Laboratory Techniques; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fluorescent Antibody Technique, Indirect; Humans; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sensitivity and Specificity; T-Lymphocytes	1996
Pentavalent antimonial-induced torsade de pointes. Journal of electrocardiology, 1997, Volume: 30, Issue:2 Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes	1997
Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:1 Topics: Adolescent; Adult; Age Distribution; Aged; Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Sex Distribution; Sicily	1997
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms	1998
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:5 Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting	1999
American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment. Bulletin of the World Health Organization, 2000, Volume: 78, Issue:8 Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Cohort Studies; Evaluation Studies as Topic; Female; Humans; Incidence; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Sensitivity and Specificity; Sex Distribution; Skin Tests	2000
Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy. AIDS (London, England), 2000, Dec-22, Volume: 14, Issue:18 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	2000
[Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana]. Medecine tropicale : revue du Corps de sante colonial, 2000, Volume: 60, Issue:3 Topics: Antiprotozoal Agents; Bedding and Linens; Clothing; French Guiana; Humans; Insect Repellents; Insecticides; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pentamidine; Recurrence; Skin; Trees	2000
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Nutrition Disorders; Organometallic Compounds; Recurrence; Retrospective Studies; Sicily; Treatment Outcome	2002
[Visceral leishmaniasis: a study of 15 cases]. Anales de medicina interna (Madrid, Spain : 1984), 1992, Volume: 9, Issue:4 Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain	1992
Recurrences of tegumentary leishmaniasis. Lancet (London, England), 1985, Sep-07, Volume: 2, Issue:8454 Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence	1985